Marina Talamonti

University of Rome Tor Vergata — Italy

Immunology and Microbiology · Life Sciences

58h-index14.3kcitations327works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(102), Pancreatic and Hepatic Oncology Research(81), Dermatology and Skin Diseases(80), Asthma and respiratory diseases(30), Autoimmune Bullous Skin Diseases(23)

Publications325 total

Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors
Journal of Dermatological Treatment·2025Open Access
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Psoriasis Targets and Therapy·2025· 1 citedOpen Access
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real‐Life Study
International Journal of Dermatology·2025· 2 cited
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Journal of Dermatological Treatment·2025· 1 citedOpen Access
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab
Dermatology Reports·2025Open Access
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
Dermatology·2025· 3 cited
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Dermatology and Therapy·2025· 11 citedOpen Access
Effects of Guselkumab on the <scp>FIB</scp> ‐4 Index in Psoriasis Patients ( <scp>EGIPT</scp> ): A Three‐Year Study
The Journal of Dermatology·2025· 2 cited
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study
Clinical and Experimental Dermatology·2025· 3 citedOpen Access
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel
Dermatology and Therapy·2025Open Access
Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies
Dermatology Reports·2025Open Access
Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy
Dermatology Practical & Conceptual·2025· 1 citedOpen Access
Leucoencefalopatía multifocal progresiva: recursos diagnósticos y evolución en una serie de casos
Neurología Argentina·2025
Comment on ‘A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council’: a case of rhabdomyolysis induced by upadacitinib
British Journal of Dermatology·2024
A microarray‐based <scp>IgE</scp>‐molecular mimicry index (<scp>IgE</scp>‐<scp>MMI</scp>): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?
Allergy·2024· 7 citedOpen Access
Video Review Can Measure Surgical Robotic Skill Development in a Resident Robotic Hernia Curriculum: A Retrospective Cohort Study
Annals of Surgery Open·2024· 4 citedOpen Access
Eczematous liraglutide eruption managed by dupilumab: A case report
JAAD Case Reports·2024· 3 citedOpen Access
Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience
Journal of Clinical Medicine·2024· 12 citedOpen Access
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis
Dermatology Reports·2024Open Access
Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?
Journal of the European Academy of Dermatology and Venereology·2024Open Access
page 1 of 17Next →

Frequent Co-authors

David J. Bentrem(17), Clifford Y. Ko(12), Karl Y. Bilimoria(11), Andrew K. Stewart(8), David P. Winchester(7), Luca Bianchi(6), Marco Galluzzo(6), Al B. Benson(5), Marshall S. Baker(4), Federico Bardazzi(4), Antonio Costanzo(4), Luca Stingeni(4), Melissa E. Hogg(3), David A. Kooby(3), Henry A. Pitt(3), Susan J. Stocker(3), Albert A. Nemcek(3), Sambasiva Rao(3), Mary F. Mulcahy(3), Kevin K. Roggin(3)